HOME HEALTH EDCL MD and CEO A. K. M. Ashrafuzzaman Working Tirelessly to Transform...
A. K. M. Ashrafuzzaman, an experienced and capable administrator, is serving as the Managing Director and CEO of Essential Drugs Company Limited (EDCL), the country’s state-owned pharmaceutical manufacturing company. Under his visionary leadership, effective management and people-oriented approach, efforts are underway to transform the strategically important state-owned institution into a more modern, efficient, self-reliant, people-centered and good-governance-driven organization.
Giving the highest priority to public interest, MD and CEO A. K. Md. Ashrafuzzaman is placing strong emphasis on increasing EDCL’s production capacity, making the best use of institutional and workforce capabilities, reducing waste and unnecessary expenditure, and ensuring the availability of quality medicines at affordable prices. Under his leadership, EDCL is working to establish itself not merely as a pharmaceutical manufacturing company, but as a strong, reliable and public-oriented state institution serving the country’s public healthcare system.
Under the leadership of A. K. M. Ashrafuzzaman, initiatives are being taken to bring positive changes in EDCL’s production and management systems while strengthening transparency, accountability, good governance, institutional capacity and operational efficiency. His vision is to strengthen EDCL’s role in protecting public health through an uninterrupted supply of quality medicines and to develop the organization into a successful, sustainable and humane state-owned institution.
MD and CEO A. K. M. Ashrafuzzaman said, “EDCL is an important state-owned pharmaceutical manufacturing institution. Ensuring an uninterrupted supply of essential medicines for the people is our primary responsibility. To achieve this objective, we must ensure the maximum utilization of our existing production capacity.”
He said, “I do not want EDCL to be seen merely as an institution that supplies medicines at lower prices. We want to enhance our capabilities and play a more effective role in the country’s public healthcare system. Ensuring quality medicines at affordable prices for the people will remain one of our major priorities.”
The Managing Director said that alongside increasing production capacity, emphasis would be placed on reducing unnecessary expenditure and wastage, making the best use of the skills and expertise of employees, and strengthening transparency and accountability in management. At the same time, initiatives will be taken to make the organization’s operations more dynamic through the use of modern technology and transparent procurement processes.
A. K. M. Ashrafuzzaman said, “Increasing production alone is not enough to move a state-owned institution forward. We must ensure efficient management, transparency, accountability and good governance. We want to give due importance to all these areas and transform EDCL into a more effective and sustainable institution.”
He said, “I want EDCL to become a humane institution. The interests of the people, production of quality medicines, welfare of employees and good governance will all receive equal importance.”
He further said, “Our goal is not merely to build a profitable institution; rather, we want to establish a strong and reliable state-owned organization that can play an effective role in ensuring the supply of essential medicines to the country’s public healthcare sector.” According to him, by maximizing production capacity, reducing wastage and unnecessary expenditure, and giving priority to public interest, EDCL can play a significant role in further strengthening the country’s healthcare system and making it more self-reliant.
